Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome

计划入组 24 人 · 首次发布于 2023 年 5 月 24 日

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome

计划入组 69 人 · 首次发布于 2017 年 2 月 16 日

Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome

计划入组 4 人 · 首次发布于 2017 年 4 月 13 日

Leigh syndrome therapeutic(Leigh syndrome)

ORAI-XXXX

Haemorrhagic Fever with Renal Syndrome Bivalent Vaccine (Vero Cell),Inactivated

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

RETT SYNDROME RESEARCH TRUST

United States

The Alarm's Mike Peters Achieves Remission from Richter's Syndrome Through NHS Drug Trial

Gedeon Richter Submits Tocilizumab Biosimilar Application to EMA for Multiple Indications

AbbVie and Gedeon Richter Expand Collaboration to Tackle Neuropsychiatric Disorders